Itinerary and guidelines for pharmacotherapeutic follow-up of Idiopathic Pulmonary Fibrosis



Description


 

 

This document constitutes a novel effort to develop and formalize, for the first time, both the description of the itinerary that the patient follows with IPF, as well as a series of recommendations and tools that allow for improvements in that care process. To achieve this objective, a working methodology based on cooperation between pneumologists and hospital pharmacists has been proposed, both in the approach and in the development of the contents of the document. This has made it possible to reach a consensus on a series of recommendations and proposals to be taken into consideration.

 

In this document, three objectives are pursued:

 

  • Propose a methodology of cooperative work between the pneumologist and the hospital pharmacist, to facilitate the complex pharmacotherapeutic follow-up of patients with this pathology.
  • Share experiences to stimulate the cooperation of the hospital pharmacist with the pneumologist.
  • Establish the route of the patient with IPF, drawing the main care processes in the Disease Management of this pathology that allow to optimize the results in health of patients with IPF "

 

Full report (in spanish)



Authors


Boehringer Ingelheim.
Con la colaboración de Antares Consulting



An Open-Innovation Test Bed for Medical Devices: Kick-off for new EU Research Project TBMED

13 European partners aim to accelerate patient access to innovative solutions

News  February 26, 2019
Copyright © 2019 Antares Consulting S.L. All rights reserved   |   Legal information and Privacy policy